DSS, INC. - 22 Sep 2026 Form 4 Insider Report for IMPACT BIOMEDICAL INC. (IBO)

Reporting relationship: 10%+ Owner
Issuer ticker: IBO
Reported as of: 22 Sep 2026
Net transaction value: -$398
SEC form: 4
Accepted by SEC: 24 Sep 2026, 19:37:56 UTC
Prior SEC filing: 27 May 2025
Source filing: View source filing
Reporting owner signature: /s/ Jason Grady

Key filing fact

DSS, INC. filed Form 4 for IMPACT BIOMEDICAL INC. (IBO) on 24 Sep 2026.

Key facts

This page summarizes DSS, INC.'s Form 4 filing for IMPACT BIOMEDICAL INC. (IBO).
3 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 24 Sep 2026, 19:37.

Change

Previous filing in this sequence was filed on 27 May 2025.
Current net transaction value: -$398.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0000771999 Primary reporting owner

DSS, INC.

Relationship: 10%+ Owner
Address: 275 WIREGRASS PKWY, HENRIETTA
Signature: /s/ Jason Grady
Signature date: 24 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IBO transaction

Common Stock

Sale

Transaction value: $398
Shares: -723
Change %: -0.12%
Price: $0.5500
Shares after: 589,701
Date: 22 Sep 2026
Ownership: Direct

IBO transaction

Common Stock

Sale

Transaction value
Shares: -27
Change %: -0%
Price: $6.95^*
Shares after: 589,674
Date: 23 Sep 2026
Ownership: Direct

IBO transaction

Common Stock

Sale

Transaction value
Shares: -156
Change %: -0.03%
Price: $7.06^*
Shares after: 589,518
Date: 24 Sep 2026
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

SEC remarks

This entity is a wholly-owned subsidiary of DSS, Inc.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .